Mark Massaro
Stock Analyst at BTIG
(2.39)
# 2,416
Out of 4,712 analysts
139
Total ratings
52.14%
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Mark Massaro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ADPT Adaptive Biotechnologies | Maintains: Buy | $8 → $9 | $6.44 | +39.75% | 5 | Dec 18, 2024 | |
| EXAS Exact Sciences | Maintains: Buy | $65 → $75 | $57.48 | +30.48% | 16 | Nov 26, 2024 | |
| BNGO Bionano Genomics | Downgrades: Neutral | n/a | $0.22 | - | 8 | Sep 10, 2024 | |
| DNA Ginkgo Bioworks Holdings | Maintains: Sell | $0.2 → $7 | $10.22 | -31.51% | 6 | Aug 23, 2024 | |
| PSNL Personalis | Maintains: Buy | $5.5 → $7 | $6.26 | +11.82% | 1 | Aug 16, 2024 | |
| ZTS Zoetis | Maintains: Buy | $220 → $225 | $165.52 | +35.94% | 2 | Aug 12, 2024 | |
| NTRA Natera | Maintains: Buy | $125 → $135 | $159.64 | -15.43% | 13 | Aug 9, 2024 | |
| AKYA Akoya Biosciences | Downgrades: Neutral | n/a | $2.46 | - | 3 | Aug 6, 2024 | |
| WGS GeneDx Holdings | Maintains: Buy | $35 → $45 | $79.45 | -43.36% | 4 | Jul 31, 2024 | |
| GH Guardant Health | Maintains: Buy | $45 → $50 | $31.37 | +59.39% | 2 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $580 | $417.11 | +39.05% | 1 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $21 | $17.28 | +21.53% | 4 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $4.07 | +96.56% | 3 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.97 | - | 1 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $2.24 | +257.14% | 8 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $3.19 | +150.78% | 2 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $38 → $30 | $27.10 | +10.70% | 4 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $5.04 | -0.79% | 3 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $25 | $21.44 | +16.60% | 2 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.66 | - | 1 | Jan 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $3.5 | $0.77 | +356.32% | 2 | Nov 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.41 | - | 2 | Jul 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $2.13 | +4,594.84% | 1 | Nov 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.11 | - | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $350 → $300 | $134.96 | +122.29% | 6 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $52 → $50 | $72.72 | -31.24% | 9 | Nov 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $112 | $153.02 | -26.81% | 10 | Jul 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $155 → $165 | $231.06 | -28.59% | 10 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $80 | $44.60 | +79.37% | 9 | Sep 10, 2018 |
Adaptive Biotechnologies
Dec 18, 2024
Maintains: Buy
Price Target: $8 → $9
Current: $6.44
Upside: +39.75%
Exact Sciences
Nov 26, 2024
Maintains: Buy
Price Target: $65 → $75
Current: $57.48
Upside: +30.48%
Bionano Genomics
Sep 10, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.22
Upside: -
Ginkgo Bioworks Holdings
Aug 23, 2024
Maintains: Sell
Price Target: $0.2 → $7
Current: $10.22
Upside: -31.51%
Personalis
Aug 16, 2024
Maintains: Buy
Price Target: $5.5 → $7
Current: $6.26
Upside: +11.82%
Zoetis
Aug 12, 2024
Maintains: Buy
Price Target: $220 → $225
Current: $165.52
Upside: +35.94%
Natera
Aug 9, 2024
Maintains: Buy
Price Target: $125 → $135
Current: $159.64
Upside: -15.43%
Akoya Biosciences
Aug 6, 2024
Downgrades: Neutral
Price Target: n/a
Current: $2.46
Upside: -
GeneDx Holdings
Jul 31, 2024
Maintains: Buy
Price Target: $35 → $45
Current: $79.45
Upside: -43.36%
Guardant Health
Jul 30, 2024
Maintains: Buy
Price Target: $45 → $50
Current: $31.37
Upside: +59.39%
Jul 25, 2024
Initiates: Buy
Price Target: $580
Current: $417.11
Upside: +39.05%
May 2, 2024
Maintains: Buy
Price Target: $23 → $21
Current: $17.28
Upside: +21.53%
Mar 13, 2024
Maintains: Buy
Price Target: $10 → $8
Current: $4.07
Upside: +96.56%
Mar 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $8.97
Upside: -
Mar 7, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $2.24
Upside: +257.14%
Mar 6, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $3.19
Upside: +150.78%
Jun 15, 2023
Maintains: Buy
Price Target: $38 → $30
Current: $27.10
Upside: +10.70%
Mar 22, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $5.04
Upside: -0.79%
Feb 28, 2023
Maintains: Buy
Price Target: $28 → $25
Current: $21.44
Upside: +16.60%
Jan 20, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.66
Upside: -
Nov 18, 2022
Maintains: Buy
Price Target: $5 → $3.5
Current: $0.77
Upside: +356.32%
Jul 7, 2022
Downgrades: Neutral
Price Target: n/a
Current: $0.41
Upside: -
Nov 30, 2020
Initiates: Buy
Price Target: $100
Current: $2.13
Upside: +4,594.84%
Oct 8, 2020
Initiates: Neutral
Price Target: n/a
Current: $1.11
Upside: -
Sep 22, 2020
Maintains: Hold
Price Target: $350 → $300
Current: $134.96
Upside: +122.29%
Nov 11, 2019
Maintains: Hold
Price Target: $52 → $50
Current: $72.72
Upside: -31.24%
Jul 24, 2019
Maintains: Buy
Price Target: $108 → $112
Current: $153.02
Upside: -26.81%
May 2, 2019
Maintains: Hold
Price Target: $155 → $165
Current: $231.06
Upside: -28.59%
Sep 10, 2018
Maintains: Buy
Price Target: $78 → $80
Current: $44.60
Upside: +79.37%